Abstract
Background: It was previously shown that inactivation of gamma-synuclein which is a small soluble neuronal protein affects psycho-emotional status and cognitive abilities in knock-out mice.
Objective: Determine the role of gamma-synuclein inactivation on memory performance in aging animals.
Method: We used the passive avoidance test and acute amphetamine administration in aging gammasynuclein knock-out mice.
Results: As a result, we found moderate aging-unlinked deficit of dopaminergic neurotransmitter system of gamma-synuclein knock-out mice. At the same time, the evidence of progressive synaptic vesicle trafficking machinery impairment was obtained.
Conclusion: Therefore most likely these dysfunctions are associated with a reduction in the highefficient learning performance in tests that require intact working memory.
Keywords: Gamma-synuclein, working memory, passive-avoidance test, and amphetamine induced locomotion, soluble proteins, neural tissue.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:The Dopaminergic Dysfunction and Altered Working Memory Performance of Aging Mice Lacking Gamma-synuclein Gene
Volume: 17 Issue: 8
Author(s): Viktor S. Kokhan, Tat`yana G. Kokhan, Anna N. Samsonova, Vladimir P. Fisenko, Aleksey A. Ustyugov and Gjumrakch Aliev*
Affiliation:
- Institute of Physiologically Active Compounds RAS, Chernogolovka,Russian Federation
Keywords: Gamma-synuclein, working memory, passive-avoidance test, and amphetamine induced locomotion, soluble proteins, neural tissue.
Abstract: Background: It was previously shown that inactivation of gamma-synuclein which is a small soluble neuronal protein affects psycho-emotional status and cognitive abilities in knock-out mice.
Objective: Determine the role of gamma-synuclein inactivation on memory performance in aging animals.
Method: We used the passive avoidance test and acute amphetamine administration in aging gammasynuclein knock-out mice.
Results: As a result, we found moderate aging-unlinked deficit of dopaminergic neurotransmitter system of gamma-synuclein knock-out mice. At the same time, the evidence of progressive synaptic vesicle trafficking machinery impairment was obtained.
Conclusion: Therefore most likely these dysfunctions are associated with a reduction in the highefficient learning performance in tests that require intact working memory.
Export Options
About this article
Cite this article as:
Kokhan S. Viktor , Kokhan G. Tat`yana, Samsonova N. Anna , Fisenko P. Vladimir , Ustyugov A. Aleksey and Aliev Gjumrakch *, The Dopaminergic Dysfunction and Altered Working Memory Performance of Aging Mice Lacking Gamma-synuclein Gene, CNS & Neurological Disorders - Drug Targets 2018; 17 (8) . https://dx.doi.org/10.2174/1871527317666180726095734
DOI https://dx.doi.org/10.2174/1871527317666180726095734 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Drug Discovery Portal: A Computational Platform for Identifying Drug Leads from Academia
Current Pharmaceutical Design Redox Behavior of Ceria Nanoparticles
Recent Patents on Materials Science Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development
Current Medicinal Chemistry Experimental Diabetes Mellitus Down-Regulates Large-Conductance Ca2+- Activated K+ Channels in Cerebral Artery Smooth Muscle and Alters Functional Conductance
Current Neurovascular Research Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication
Current Pharmaceutical Design Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimers Disease Pharmacogenetics
Current Alzheimer Research Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Current Organic Chemistry Most Recent Developments and Modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan Derivatives
Mini-Reviews in Medicinal Chemistry The Role of Matrix Metalloproteinases in Essential Hypertension
Current Topics in Medicinal Chemistry Calculating Water Thermodynamics in the Binding Site of Proteins – Applications of WaterMap to Drug Discovery
Current Topics in Medicinal Chemistry The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review
Current HIV Research Cannabis Use and Psychosis: Theme Introduction
Current Pharmaceutical Design The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors
Current Pharmaceutical Design Soy Isoflavone Alleviates Aβ1-42-Induced Impairment of Learning and Memory Ability Through the Regulation of RAGE/LRP-1 in Neuronal and Vascular Tissue
Current Neurovascular Research A Review of the Three-Dimensional Cell Culture Technique: Approaches, Advantages and Applications
Current Stem Cell Research & Therapy The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) The Immune System Regulation in Sepsis: From Innate to Adaptive
Current Protein & Peptide Science Neurofunctional Correlates of Theory of Mind Deficits in Schizophrenia
Current Topics in Medicinal Chemistry Histone Deacetylase Inhibition: A Differentiation Therapy for Cultured Primary Hepatocytes?
Current Enzyme Inhibition